164 related articles for article (PubMed ID: 26035355)
1. Tensin4 is up-regulated by EGF-induced ERK1/2 activity and promotes cell proliferation and migration in hepatocellular carcinoma.
Chan LK; Chiu YT; Sze KM; Ng IO
Oncotarget; 2015 Aug; 6(25):20964-76. PubMed ID: 26035355
[TBL] [Abstract][Full Text] [Related]
2. C-terminal tensin-like (CTEN): a promising biomarker and target for cancer.
Lo SH
Int J Biochem Cell Biol; 2014 Jun; 51():150-4. PubMed ID: 24735711
[TBL] [Abstract][Full Text] [Related]
3. C-terminal tensin-like gene functions as an oncogene and promotes cell motility in pancreatic cancer.
Al-Ghamdi S; Cachat J; Albasri A; Ahmed M; Jackson D; Zaitoun A; Guppy N; Otto WR; Alison MR; Kindle KB; Ilyas M
Pancreas; 2013 Jan; 42(1):135-40. PubMed ID: 22750970
[TBL] [Abstract][Full Text] [Related]
4. C-terminal tensin-like protein mediates invasion of human lung cancer cells and is regulated by signal transducer and activator of transcription 3.
Bennett DT; Reece TB; Foley LS; Sjoberg A; Meng X; Fullerton DA; Weyant MJ
J Thorac Cardiovasc Surg; 2015 Jan; 149(1):369-75. PubMed ID: 25439778
[TBL] [Abstract][Full Text] [Related]
5. Tensin2 variant 3 is associated with aggressive tumor behavior in human hepatocellular carcinoma.
Yam JW; Ko FC; Chan CY; Yau TO; Tung EK; Leung TH; Jin DY; Ng IO
Hepatology; 2006 Oct; 44(4):881-90. PubMed ID: 17006924
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor modulates tyrosine phosphorylation of a novel tensin family member, tensin3.
Cui Y; Liao YC; Lo SH
Mol Cancer Res; 2004 Apr; 2(4):225-32. PubMed ID: 15140944
[TBL] [Abstract][Full Text] [Related]
7. The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment.
Huang P; Xu X; Wang L; Zhu B; Wang X; Xia J
J Cell Mol Med; 2014 Feb; 18(2):218-30. PubMed ID: 24268047
[TBL] [Abstract][Full Text] [Related]
8. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between the expression of C-terminal tensin-like protein and the prognosis of hepatocellular carcinoma].
Chen J; Zhang Y; Deng G; Ma J; Wu X; Qu Y; Zeng S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Dec; 39(12):1233-9. PubMed ID: 25544169
[TBL] [Abstract][Full Text] [Related]
10. CD147 promotes Src-dependent activation of Rac1 signaling through STAT3/DOCK8 during the motility of hepatocellular carcinoma cells.
Wang SJ; Cui HY; Liu YM; Zhao P; Zhang Y; Fu ZG; Chen ZN; Jiang JL
Oncotarget; 2015 Jan; 6(1):243-57. PubMed ID: 25428919
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E₂ receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells.
Bai X; Wang J; Zhang L; Ma J; Zhang H; Xia S; Zhang M; Ma X; Guo Y; Rong R; Cheng S; Shu W; Wang Y; Leng J
Int J Oncol; 2013 May; 42(5):1833-41. PubMed ID: 23525457
[TBL] [Abstract][Full Text] [Related]
12. Tensins: a new switch in cell migration.
Mouneimne G; Brugge JS
Dev Cell; 2007 Sep; 13(3):317-9. PubMed ID: 17765673
[TBL] [Abstract][Full Text] [Related]
13. A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration.
Katz M; Amit I; Citri A; Shay T; Carvalho S; Lavi S; Milanezi F; Lyass L; Amariglio N; Jacob-Hirsch J; Ben-Chetrit N; Tarcic G; Lindzen M; Avraham R; Liao YC; Trusk P; Lyass A; Rechavi G; Spector NL; Lo SH; Schmitt F; Bacus SS; Yarden Y
Nat Cell Biol; 2007 Aug; 9(8):961-9. PubMed ID: 17643115
[TBL] [Abstract][Full Text] [Related]
14. Des-γ-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathway.
Yue P; Gao ZH; Xue X; Cui SX; Zhao CR; Yuan Y; Yin Z; Inagaki Y; Kokudo N; Tang W; Qu XJ
Eur J Cancer; 2011 May; 47(7):1115-24. PubMed ID: 21349701
[TBL] [Abstract][Full Text] [Related]
15. Cten, a COOH-terminal tensin-like protein with prostate restricted expression, is down-regulated in prostate cancer.
Lo SH; Lo TB
Cancer Res; 2002 Aug; 62(15):4217-21. PubMed ID: 12154022
[TBL] [Abstract][Full Text] [Related]
16. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of FoxM1 promotes the tumor cell proliferation in hepatocellular carcinoma.
Yu M; Tang Z; Meng F; Tai M; Zhang J; Wang R; Liu C; Wu Q
Tumour Biol; 2016 Jan; 37(1):1289-97. PubMed ID: 26289845
[TBL] [Abstract][Full Text] [Related]
18. Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness.
de la Monte SM; Tamaki S; Cantarini MC; Ince N; Wiedmann M; Carter JJ; Lahousse SA; Califano S; Maeda T; Ueno T; D'Errico A; Trevisani F; Wands JR
J Hepatol; 2006 May; 44(5):971-83. PubMed ID: 16564107
[TBL] [Abstract][Full Text] [Related]
19. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
20. CTEN prolongs signaling by EGFR through reducing its ligand-induced degradation.
Hong SY; Shih YP; Li T; Carraway KL; Lo SH
Cancer Res; 2013 Aug; 73(16):5266-76. PubMed ID: 23774213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
